OSUR — OraSure Technologies Share News
0.000.00%
- $262.77m
- $102.39m
- $115.02m
Brief: Orasure Technologies Confirms Receipt Of Director Nominations From Altai Capital
Brief: Altai Capital Management Nominates Two Highly-Qualified Candidates For Election To Orasure Board Of Directors
Brief: Orasure Submits Ct/Ng Molecular Self-Test And Colli-Pee™ Urine Collection Device For FDA Review
Brief: OraSure Issues Statement Regarding Altai’S Intent To Nominate Director Candidates
Brief: Altai Capital to Nominate Two Candidates for OraSure Board
OraSure misses Q3 revenue estimates
Brief: OraSure Technologies Q3 Revenue USD 27.1 Million
Brief: OraSure Technologies Appoints Steven K. Boyd To Its Board Of Directors
Altai Capital lays groundwork for board fight at OraSure Technologies, sources say
Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid
OraSure Technologies Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: OraSure Technologies Q2 Revenue USD 31.2 Million
Brief: OraSure Appoints Anne Messing As Chief Commercial Officer
OraSure Technologies Inc expected to post a loss of 20 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
OraSure Technologies received takeover bid from industry entrepreneur, sources say
Brief: Orasure Technologies Inc Files For Mixed Shelf Of Up To $300 Million - SEC Filing
OraSure Technologies Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: OraSure Technologies Q1 Revenue USD 29.9 Million